Evaluation of Yucatan micropig skin for use as an in vitro model for skin permeation study

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 3, 1997, Pages 249-254

  Fujii, Makiko ^a   Yamanouchi, Shizuka ^a   Hori, Naohide ^b   Iwanaga, Noriko ^a   Kawaguchi, Naruko ^a   Matsumoto, Mitsuo ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

animal model; in vitro; non steroidal anti inflammatory drug; skin permeation; Yucatan hairless micropig

Indexed keywords

DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENAZONE;

AGE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; HUMAN; HUMAN TISSUE; HYDROPHILICITY; LIPOPHILICITY; NONHUMAN; PARTITION COEFFICIENT; RAT; REPRODUCIBILITY; SKIN PERMEABILITY; SWINE;

EID: 0030892811     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.249     Document Type: Article

References (16)

1. Shah V. P., Maibach H. I. (ed.), "Topical Drug Bioavailability, Bioequivalence, and Penetration," Plenum Press, New York, 1993, pp. 333-349.
2. Hinz R. S., Hodson C. D., Lorence C. R., Guy R. H., J. Invest. Dermatol., 93, 87-91 (1989).
3. Bond J. R., Barry B. W., Int. J. Pharmaceut., 41, 91-93 (1988).
4. Bond J. R., Barry B. W., J. Invest. Dermatol., 90, 810-813 (1988).
5. Catz P., Friend D. R., Int. J. Pharmaceut., 58, 93-102 (1990).
6. Hawkins G. S., Jr., Reifenrath W. G., Fundam. Appl. Toxicol., 4, S133-S144 (1984).
7. Dick I. P., Scott R. C., J. Pharm. Pharmacol., 44, 640-645 (1992).
8. Monteiro-Riviere N. A., Inman A. O., Riviere J. E., MacNeill S. C., Francoeur M. L., Pharm. Res., 9, 1326-1331 (1993).
9. Fang J.-Y., Wu P.-C., Huang Y.-B., Tsai Y.-H., Int. J. Pharmaceut., 130, 121-135 (1996).
10. Kurihara-Bergstrom T., Woodworth M., Feisullin S., Beall P., Lab. Animal Sci., 36, 396-399 (1986).
11. Roberts M. E., Mueller K. R., Pharm. Res., 7, 673-676 (1990).
12. Lavker R. M., Dong G., Zheng P., Murphy G. F., American J. Pathology, 138, 687-697 (1991).
13. Ozeki Y., Kawabe H., Shimizu T., Tsukamoto K., Nakano K., Hayashi M., Tsurumi K., Oyo Yakuri, 48, 511-531 (1994).
14. Morimoto Y., Hatanaka T., Sugibayashi K., Omiya H., J. Pharm. Pharmacol., 44, 634-639 (1992).
15. Pamphlet from Charles River Laboratories, "Swine".
16. Shah V. P., Maibach H. I. (ed.), "Topical Drug Bioavailability, Bioequivalence, and Penetration," Plenum Press, New York, 1993, pp. 3-9.